⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ERAS News
Erasca, Inc. Common Stock
Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
globenewswire.com
ERAS
Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
globenewswire.com
ERAS
Erasca Announces Pricing of Upsized Public Offering of Common Stock
globenewswire.com
ERAS
Erasca Announces Proposed Public Offering of $150 Million of Common Stock
globenewswire.com
ERAS
Erasca Announces Proposed Public Offering of $150 Million of Common Stock
globenewswire.com
ERAS
Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape
prnewswire.com
GTBP
IBRX
ERAS
CHRS
NBP
Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff
prnewswire.com
ONCY
NRIX
ERAS
FHTX
ORIC
Erasca Announces Promising Early Clinical Data for ERAS-0015 and 2026-2027 Milestones
globenewswire.com
ERAS
Erasca to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
ERAS
Platform Technologies Drive $211B Surge in Precision Cancer Treatment
prnewswire.com
GTBP
ERAS
FHTX
OABI
RXRX